Genentech Access To Care Foundation (Avastin, Herceptin, Rituxan), a patient assistance program provided by Genentech, Inc., offers the medications listed to the right at no cost to those who are eligible for the program. Eligibility is based off of the following requirements: - You must meet an undisclosed income and insurance guidelines.
Full Answer
What is the Genentech patient Foundation?
Genentech Patient Foundation Living with a serious illness can come with many challenges. Getting Genentech medicines shouldn’t be one of them. The Genentech Patient Foundation gives free Genentech medicine to people who don’t have insurance coverage or who have financial concerns.
How can I get Free Genentech medicine?
‡ To be eligible for free Genentech medicine from the Genentech Patient Foundation, insured patients who have coverage for their medicine should try to pursue other forms of financial assistance, if available, and meet certain income requirements.
Does *Genentech guarantee co-pay assistance after a referral?
*Genentech does not influence or control the operations or eligibility criteria of any independent co-pay assistance foundation and cannot guarantee co-pay assistance after a referral from ACTEMRA Access Solutions. The foundations to which we refer patients are not exhaustive or indicative of Genentech’s endorsement or financial support.
What is Genentech doing for patients with AIS?
At Genentech, we are dedicated to supporting healthcare providers and their institutions in delivering quality care to patients. The following resources were developed to help healthcare professionals with treating patients with AIS and the appropriate use of Activase®. Filter by Activase for Acute Ischemic Stroke Show All
See more
What Is Genentech Access Solutions?
Access Solutions is a program from Genentech and is committed to helping you understand your insurance coverage and options that might be able to help you pay for your Genentech medicine. Call (866) 422-2377 or visit Genentech-Access.com for more information.
What is the Genentech Patient Foundation?
The Genentech Patient Foundation gives free Genentech medicine to people who don't have insurance coverage or who have financial concerns.
What is the Pfizer Patient Assistance Program?
Pfizer Patient Assistance Program Provides free Pfizer medicines to eligible patients through their doctor's office or at home. To qualify, patients must: Have a valid prescription for the Pfizer medicine for which they are seeking assistance.
What drugs does Genentech make?
Our Medicines & ProductsMedicines.Actemra® (TOCILIZUMAB [authorized for Emergency Use])Actemra® (tocilizumab)Activase® (alteplase)Alecensa® (alectinib)Avastin® (bevacizumab)Boniva Tablets® (ibandronate sodium)Cathflo Activase® (alteplase)More items...
How do you qualify for free eliquis?
You may be eligible for the Free 30-Day Trial Offer for ELIQUIS® (apixaban) if:You have not previously filled a prescription for ELIQUIS;You have a valid 30-day prescription for ELIQUIS;You are being treated with ELIQUIS for an FDA-approved indication that an HCP has planned for more than 35 days of treatment;More items...
Which Pfizer blood pressure medication is being recalled?
The drugs in the Pfizer recall include certain batches of Accupril (quinapril hydrochloride) tablets and Accuretic (quinapril hydrochloride plus hydrochlorothiazide) tablets distributed by Pfizer, as well as two related generic formulations distributed by Greenstone.
Does Viatris have a patient assistance program?
The Viatris Patient Assistance Program provides certain medicines for free to patients with demonstrated financial need. Viatris is committed to helping patients get the treatments they need, when and where they need them.
What is Genentech best known for?
Genentech is a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases. Our transformational discoveries include the first targeted antibody for cancer and the first medicine for primary progressive multiple sclerosis.
Who is Genentech owned by?
As of July 2021, Genentech employed 13,539 people....Genentech.TypePrivate ( Independent subsidiary)Number of employees13,539 (July 2021)ParentHoffmann-La RocheWebsitewww.gene.com7 more rows
Why did Roche buy Genentech?
For another, Roche went into the deal with the goal of preserving the innovative, entrepreneurial culture that had transformed Genentech from a start-up to a standout, one that had developed Roche's three best-selling products — the cancer drugs Avastin, Herceptin and Rituxan.
What is Genentech famous?
Genentech is a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases. Our transformational discoveries include the first targeted antibody for cancer and the first medicine for primary progressive multiple sclerosis.
Who acquired Genentech?
Roche Holding'sRoche Holding's agreement on Thursday to acquire full ownership of Genentech for $46.8 billion is the third big drug industry merger this year.
Where is Genentech headquarters?
South San Francisco, CAGenentech / HeadquartersGenentech's corporate headquarters are in South San Francisco, California (37.657°N 122.379°W), with additional manufacturing facilities in Vacaville, California; Oceanside, California; and Hillsboro, Oregon.
Who started Genentech?
Robert A. SwansonHerbert BoyerGenentech/Founders
What is Genentech dedicated to?
At Genentech, we are dedicated to supporting healthcare providers and their institutions in delivering quality care to patients. The following resources were developed to provide disease education resources to help in diagnosing and assessing stroke.
What is activase resource center?
Activase Resource Center: Supporting you in the treatment of acute ischemic stroke (AIS) patients
What are the risks of activase?
In the following conditions, the risks of bleeding with Activase are increased and should be weighed against the anticipated benefits: recent major surgery or procedure; cerebrovascular disease; recent intracranial hemorrhage; recent gastrointestinal or genitourinary bleeding; recent trauma; hypertension; acute pericarditis; subacute bacterial endocarditis; hemostatic defects including those secondary to severe hepatic or renal disease; significant hepatic dysfunction; pregnancy; diabetic hemorrhagic retinopathy or other hemorrhagic ophthalmic conditions; septic thrombophlebitis or occluded AV cannula at seriously infected site; advanced age; and patients currently receiving oral anticoagulants, or any other condition in which bleeding constitutes a significant hazard or would be particularly difficult to manage because of its location.
What is the most common adverse reaction associated with activase therapy?
The most frequent adverse reaction associated with Activase therapy is bleeding.
How soon after stroke can you start activase?
Initiate treatment as soon as possible but within 3 hours after symptom onset. Activase is indicated for use in acute myocardial infarction (AMI) for the reduction of mortality and reduction of the incidence of heart failure.
How many mg of activase is in a vial?
Video: Dosing and Administration With Activase® (alteplase) 50-mg vials
Can activase cause anaphylactic reactions?
Hypersensitivity, including urticarial / anaphylactic reactions, have been reported after administration of Activase. Rare fatal outcome for hypersensitivity was reported. Angioedema has been observed during and up to 2 hours after Activase infusion in patients treated for acute ischemic stroke and acute myocardial infarction. In many cases, patients received concomitant angiotensin-converting enzyme inhibitors. Monitor patients treated with Activase during and for several hours after infusion for hypersensitivity. If signs of hypersensitivity occur, e.g. anaphylactoid reaction or angioedema develops, discontinue the Activase infusion and promptly institute appropriate therapy (e.g., antihistamines, intravenous corticosteroids, epinephrine).
Important Note
The following information is intended to supplement, not substitute for, the expertise and judgment of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that use of the drug is safe, appropriate, or effective for you. Consult your healthcare professional before using this drug.
Uses
This medication is an enzyme which works to break up and dissolve blood clots which can block arteries. It is used in the treatment of an acute heart attack or pulmonary embolism.
How To Use
This medication is given by injection within 6 hours of chest pain by a health care professional. It is usually given over a two to three hour period. Continued or repeated doses are not usually required. It is important this medication be used as prescribed.
Side Effects
Nausea, vomiting, dizziness or mild fever may occur. If any of these effects continue or become bothersome, inform your doctor. Notify your doctor if you experience: easy bruising or bleeding, skin rash, trouble breathing, rapid or abnormal heartbeat, chest pain. Immediately report any signs of bleeding to your doctor.
Precautions
Tell your doctor your medical history, especially of: bleeding disorders, high blood pressure, recent injury or surgery, liver disease, endocarditis, any allergies. Use extra caution to avoid injury and trauma while using this medication due to the increased risk of bleeding. This medication should be used only if clearly needed during pregnancy.
Drug Interactions
Tell your doctor of any over-the-counter or prescription medication you may take including: "blood thinners" (e.g., warfarin), aspirin. Do not start or stop any medicine without doctor or pharmacist approval.
Overdose
If overdose is suspected, contact your local poison control center or emergency room immediately. Symptoms of overdose may include fainting, vision changes, one-sided weakness, slurred speech, black stools, coughing up or vomiting blood, dizziness upon standing.
What is the most common adverse reaction associated with activase therapy?
The most frequent adverse reaction associated with Activase therapy is bleeding.
What are the risks of activase?
In the following conditions, the risks of bleeding with Activase are increased and should be weighed against the anticipated benefits: recent major surgery or procedure; cerebrovascular disease; recent intracranial hemorrhage; recent gastrointestinal or genitourinary bleeding; recent trauma; hypertension; acute pericarditis; subacute bacterial endocarditis; hemostatic defects including those secondary to severe hepatic or renal disease; significant hepatic dysfunction; pregnancy; diabetic hemorrhagic retinopathy or other hemorrhagic ophthalmic conditions; septic thrombophlebitis or occluded AV cannula at seriously infected site; advanced age; and patients currently receiving oral anticoagulants, or any other condition in which bleeding constitutes a significant hazard or would be particularly difficult to manage because of its location.
How long after activase infusion can you get angioedema?
Angioedema has been observed during and up to 2 hours after Activase infusion in patients treated for acute ischemic stroke and acute myocardial infarction. In many cases, patients received concomitant angiotensin-converting enzyme inhibitors.
Can activase be used for pulmonary embolism?
Do not administer Activase to treat acute myocardial infarction or pulmonary embolism in the following situations in which the risk of bleeding is greater than the potential benefit: active internal bleeding; history of recent stroke; recent (within 3 months) intracranial or intraspinal surgery or serious head trauma; presence of intracranial conditions that may increase the risk of bleeding; bleeding diathesis; and current severe uncontrolled hypertension.
Can activase be used for ischemic stroke?
Do not administer Activase to treat acute ischemic stroke in the following situations in which the risk of bleeding is greater than the potential benefit: current intracranial hemorrhage (ICH); subarachnoid hemorrhage; active internal bleeding; recent (within 3 months) intracranial or intraspinal surgery or serious head trauma; presence of intracranial conditions that may increase the risk of bleeding (e.g., some neoplasms, arteriovenous malformations, or aneurysms); bleeding diathesis; and current severe uncontrolled hypertension.
Does activase help with thromboembolism?
Thromboembolism. The use of thrombolytics can increase the risk of thrombo-embolic events in patients with high likelihood of left heart thrombus, such as patients with mitral stenosis or atrial fibrillation. Activase has not been shown to treat adequately underlying deep vein thrombosis in patients with PE.
Can activase cause bleeding?
Activase can cause significant, sometimes fatal internal or external bleeding, especially at arterial and venous puncture sites . Avoid intramuscular injections and trauma to the patient. Perform venipunctures carefully and only as required.